Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Some skin patients have body image issues linked to social difficulties but want psychological help.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

AB+ blood group is more common in alopecia areata patients.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Some patients' hair grew back black and white after chemotherapy.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

New cytokine-targeted therapies show promise for treating alopecia areata.

Baricitinib is an effective treatment for severe alopecia areata.

There is no significant link between metabolic syndrome and alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

A genetic mutation in the CDH3 gene causes hair loss and vision problems in a young Saudi girl.

Alopecia Areata patients have low zinc and high copper levels.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.